Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors | stella

Back to Quality of Life (QOL) trials

Recruiting

Plain-English translation of NCT07829081 on ClinicalTrials.gov ↗ · Source last updated September 2026 · How we translate trials

Trial locations(3 sites)

Switzerland

Universitätsspital Basel, Basel

Spitalzentrum Biel, Biel

Luzerner Kantonsspital, Lucerne

Key details

Sponsor

University Hospital, Basel, Switzerland

Enrollment target

~234 participants

Started

September 2026

Primary completion

August 2033

Age range

18 Years and older

Last updated on clinicaltrials.gov in September 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Dieter Köberle, Prof. Dr. med.

University Hospital, Basel, Switzerland

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov